Hints and tips:
Related Special Reports
...In October 2019, Merck also completed a €5.8bn acquisition of US-based Versum Materials, which makes critical components used in semiconductors. Merck declined to comment....
...Merck, which employs 64,000 people, is the world’s oldest pharmaceutical company, tracing its history back to 1668. The founding family still owns 70 per cent of the company....
...“We are very disappointed with the results,” said Merck’s global head of research and development and its healthcare business chief medical officer Danny Bar-Zohar, adding that the company would continue...
...Merck Mercuriadis, adviser to Hipgnosis Songs Fund, has offered to drop a controversial clause giving him the right to buy the group’s music portfolio as he battles to stay on at the investment trust he...
...Merck KGaA chief Belén Garijo will be all too aware of the highs and sudden crushing lows of drug trials....
...The Swiss company already has a packed pipeline. The problem is that too many drug trials have failed. Merck knows how that feels....
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Shares in Daiichi Sankyo jumped as much as 18 per cent after it agreed on a deal worth up to $22bn with Merck to develop and commercialise three of the Japanese pharmaceutical company’s drug candidates to...
...And what are the incentives of Merck Mercuriadis after the transaction?...
...The company reported a loss of $2.06 a share, which was mainly due to a charge related to an acquisition....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...Investment adviser and music mogul Merck Mercuriadis was a frontman as crowd-pleasing as any stadium rocker The net asset value rose from a few hundred million dollars to $2.2bn at the end of last year....
...Merck Mercuriadis, who established Hipgnosis in 2018 and is now chief executive of the fund’s investment adviser — Hipgnosis Song Management — said the AGM “marks an opportunity to reset and focus on the...
...Yet the company’s monoclonal antibody treatment for inflammatory bowel disease has yet to be fully approved....
...Merck said the deal would strengthen the company’s position in the fast-growing field of immunology, where there is significant unmet patient need....
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
...Hipgnosis was founded by music executive Merck Mercuriadis in 2018 to turn music rights into a mainstream asset class, using the royalties from streaming, radio play and performances to provide income for...
...Hipgnosis was founded by music executive Merck Mercuriadis in 2018 to turn music rights into a mainstream asset class....
...HSF was founded by music executive Merck Mercuriadis in 2018 to turn music rights into an asset class. He was HSM’s chief executive until February, when he became its chair....
...Merck Mercuriadis, a former manager of stars including Beyoncé and Elton John, established Hipgnosis in 2018 and listed it in London as an investment trust....
...This week, US pharmaceutical company Merck announced it would acquire Prometheus Biosciences for $10.8bn, following in the footsteps of Pfizer’s $43bn deal for Seagen and Amgen’s $28bn acquisition of Horizon...
...Other earnings: Merck, Caterpillar, Honeywell, Bristol Myers Squibb, Altria, Northrop Grumman, Royal Caribbean Cruises, Southwest Airlines, American Airlines, Harley-Davidson and Hertz are reporting before...
...Hipgnosis was founded by music executive Merck Mercuriadis in 2018 to turn music rights into a mainstream asset class, using the rising royalties from streaming, radio play and performances to provide income...
International Edition